Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
Himmerich
Hubertus
H
Ehrlinger
Martin
M
Hackenberg
Melanie
M
Löhr
Birgit
B
Nickel
Thomas
T
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D003863:Depression / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D000069348:Quetiapine Fumarate; D012206:Rhabdomyolysis / Q000097:blood / Q000139:chemically induced*
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D005473:Fluoxetine; D000069348:Quetiapine Fumarate; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase